Hepatitis C's effect on HIV disease remains elusive despite three new studies
Kuru experiments triggered the emergence of pathogenic SIVmac
Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort
A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection
Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection
Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients
Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients
Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response
GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals
Altered hepatic expression of SREBP-1 and PPARγ is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients
Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjects
Sustained control of viremia following therapeutic immunization in chronically HIV-1-infected individuals
Multidrug-resistant tuberculosis at an HIV testing center in Haiti
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV
Mode of delivery and postpartum HIV-1 disease progression: The Women and Infants Transmission Study
Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990–2003
Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia
Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons
Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART
Hyperglycosylated ferritin in sera of HIV-1-infected patients treated with highly active antiretroviral therapy
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort
Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev
Considerations about the value of sonography for the measurement of regional body fat
Graves disease: an increasingly recognized immune reconstitution syndrome
Inflammatory progressive multifocal leukoencephalopathy after antiretroviral treatment
First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases
‘Tuberculosis’ after commencing antiretroviral therapy in HIV patients from countries where Mycobacterium tuberculosis infection is common
Merkel cell carcinoma in an HIV-1-infected man
Impact of MCP-1-2518-G allele on the HIV-1 disease of children in the United States
Surplus men, sex work, and the spread of HIV in China